Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Perrigo Co Announces FDA Final Approval For Generic Equivalent To Cutivate Lotion, 0.05%


Wednesday, 31 Jul 2013 09:00am EDT 

Perrigo Company announced that it has received final approval for its abbreviated new drug application for fluticasone propionate lotion, 0.05%, the generic equivalent to Cutivate Lotion, 0.05%. Perrigo will commence shipment of the product immediately. Cutivate Lotion 0.05% (fluticasone propionate lotion, 0.05%) is indicated for the relief of the inflammatory and pruritic manifestations of atopic dermatitis in patients 1 year of age or older. 

Company Quote

168.14
3.29 +2.00%
19 Dec 2014